Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma

Malignant glioma is the most common brain cancer with dismal outcomes. Individual variation of the patients’ survival times is remarkable. Here, we investigated the transcriptome and promoter methylation differences between patients of malignant glioma with short (less than one year) and the patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Huimin, Wang, Zheng, Li, Mingyang, Zeng, Fan, Wang, Kuanyu, Huang, Ruoyu, Wang, Haoyuan, Yang, Fan, Liang, Tingyu, Huang, Hua, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599690/
https://www.ncbi.nlm.nih.gov/pubmed/28912488
http://dx.doi.org/10.1038/s41598-017-11962-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599690/
https://www.ncbi.nlm.nih.gov/pubmed/28912488
http://dx.doi.org/10.1038/s41598-017-11962-y

Ejemplares similares